Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization Publisher Pubmed



Sun J1, 3 ; Henry DA2 ; Carr MJ1 ; Yazdankhahkenary A1, 4 ; Laronga C1 ; Lee MC1 ; Hoover SJ1 ; Sun W1 ; Czerniecki BJ1 ; Khakpour N1 ; Kiluk JV1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Breast Oncology, Moffitt Cancer Center, Tampa, FL, United States
  2. 2. Breast Care Center, Orlando Health - UF Health Cancer Center, Orlando, FL
  3. 3. Present affiliation: Department of Surgery, University Hospitals, Cleveland Medical Center, Cleveland, OH
  4. 4. Present affiliation: Tehran University of Medical Sciences, Tehran, Iran, Iran

Source: Clinical Breast Cancer Published:2021


Abstract

Introduction: Neoadjuvant chemotherapy (NAC) is commonly used for patients with clinically detected nodal metastases. Sentinel lymph node biopsy (SLNB) after NAC is feasible. Excision of biopsy-proven positive lymph nodes in addition to SLNB, termed targeted axillary dissection (TAD), decreases the false-negative rate of SLNB alone. Positive nodes can be marked with radar reflector-localization (RRL) clips. We report our institutional experience with RRL-guided TAD and demonstrate its safety and feasibility. Patients and Methods: We performed an institutional review board-approved retrospective review of consecutive clinically node-positive female patients with breast cancer treated with NAC and RRL-guided TAD between January 2017 and September 2019. Clinicopathologic and treatment data were collected; descriptive statistics are reported. Results: Forty-five patients were analyzed; the median age was 55 years (range, 20-72 years), and the median body mass index was 27.2 kg/m2 (range, 16.5-40.4 kg/m2). All patients received NAC, primary breast surgery, and TAD. All clinically detected nodal metastases were confirmed with percutaneous biopsy and marked with a biopsy clip. RRL clips were implanted a median of 8 days (range, 1-167 days) prior to surgery; all were retrieved without complications. The RRL node was identified as the sentinel lymph node in 36 (80%) patients. Twenty-five patients had positive nodes, of which 24 were identified by RRL node excision, and 1 (4%) patient had a positive node identified by SLNB but not RRL. Over a median follow-up time of 29.6 months, 5 patients recurred (1 local, 4 distant). Conclusions: RRL-guided TAD after NAC is safe and feasible. This technique allows for adequate assessment of the nodal basin and helps confirm excision of the previously biopsied positive axillary node. © 2020 Elsevier Inc.